JP6049258B2 - コンパニオン動物における精神活動の加齢劣化を減少させる組成物及び方法 - Google Patents
コンパニオン動物における精神活動の加齢劣化を減少させる組成物及び方法 Download PDFInfo
- Publication number
- JP6049258B2 JP6049258B2 JP2011289115A JP2011289115A JP6049258B2 JP 6049258 B2 JP6049258 B2 JP 6049258B2 JP 2011289115 A JP2011289115 A JP 2011289115A JP 2011289115 A JP2011289115 A JP 2011289115A JP 6049258 B2 JP6049258 B2 JP 6049258B2
- Authority
- JP
- Japan
- Prior art keywords
- amount
- vitamin
- weight
- methionine
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims description 33
- 230000006866 deterioration Effects 0.000 title claims description 13
- 238000000034 method Methods 0.000 title claims description 7
- 241001465754 Metazoa Species 0.000 title description 8
- 230000003340 mental effect Effects 0.000 title description 5
- 241000282326 Felis catus Species 0.000 claims description 37
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 35
- 229910052717 sulfur Inorganic materials 0.000 claims description 35
- 239000011593 sulfur Substances 0.000 claims description 35
- 239000003963 antioxidant agent Substances 0.000 claims description 33
- 235000006708 antioxidants Nutrition 0.000 claims description 33
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 30
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 30
- 235000005911 diet Nutrition 0.000 claims description 30
- 230000037213 diet Effects 0.000 claims description 29
- 229930182817 methionine Natural products 0.000 claims description 21
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 20
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 20
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 20
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 19
- 235000018417 cysteine Nutrition 0.000 claims description 19
- 230000003078 antioxidant effect Effects 0.000 claims description 17
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 14
- 229930003268 Vitamin C Natural products 0.000 claims description 14
- 229930003427 Vitamin E Natural products 0.000 claims description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 14
- 235000019154 vitamin C Nutrition 0.000 claims description 14
- 239000011718 vitamin C Substances 0.000 claims description 14
- 235000019165 vitamin E Nutrition 0.000 claims description 14
- 239000011709 vitamin E Substances 0.000 claims description 14
- 229940046009 vitamin E Drugs 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 13
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 12
- 239000006014 omega-3 oil Substances 0.000 claims description 12
- 235000007882 dietary composition Nutrition 0.000 claims description 10
- 229960004203 carnitine Drugs 0.000 claims description 9
- 230000003923 mental ability Effects 0.000 claims description 9
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 8
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 8
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims description 8
- 230000003247 decreasing effect Effects 0.000 claims description 7
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 6
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 6
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 6
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 6
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 5
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 5
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 5
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 4
- 229960004488 linolenic acid Drugs 0.000 claims description 4
- 230000036997 mental performance Effects 0.000 claims description 2
- 229960001518 levocarnitine Drugs 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 description 18
- 229940024606 amino acid Drugs 0.000 description 18
- 150000001413 amino acids Chemical class 0.000 description 16
- 235000013305 food Nutrition 0.000 description 12
- 230000003542 behavioural effect Effects 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 230000032683 aging Effects 0.000 description 7
- -1 methyl hydroxy Chemical group 0.000 description 7
- 208000010877 cognitive disease Diseases 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 208000027382 Mental deterioration Diseases 0.000 description 4
- 206010027374 Mental impairment Diseases 0.000 description 4
- XVOYSCVBGLVSOL-UHFFFAOYSA-N cysteic acid Chemical compound OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 231100000028 nontoxic concentration Toxicity 0.000 description 4
- 108010024636 Glutathione Proteins 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- YPWSLBHSMIKTPR-UHFFFAOYSA-N Cystathionine Natural products OC(=O)C(N)CCSSCC(N)C(O)=O YPWSLBHSMIKTPR-UHFFFAOYSA-N 0.000 description 2
- ILRYLPWNYFXEMH-UHFFFAOYSA-N D-cystathionine Natural products OC(=O)C(N)CCSCC(N)C(O)=O ILRYLPWNYFXEMH-UHFFFAOYSA-N 0.000 description 2
- 241000282324 Felis Species 0.000 description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 2
- ILRYLPWNYFXEMH-WHFBIAKZSA-N L-cystathionine Chemical compound [O-]C(=O)[C@@H]([NH3+])CCSC[C@H]([NH3+])C([O-])=O ILRYLPWNYFXEMH-WHFBIAKZSA-N 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- QEFRNWWLZKMPFJ-UHFFFAOYSA-N L-methionine sulphoxide Natural products CS(=O)CCC(N)C(O)=O QEFRNWWLZKMPFJ-UHFFFAOYSA-N 0.000 description 2
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 229960004308 acetylcysteine Drugs 0.000 description 2
- 229960001570 ademetionine Drugs 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 235000011649 selenium Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- NMMHHSLZJLPMEG-UHFFFAOYSA-N 2-(chloroamino)ethanesulfonic acid Chemical compound OS(=O)(=O)CCNCl NMMHHSLZJLPMEG-UHFFFAOYSA-N 0.000 description 1
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 1
- ADVPTQAUNPRNPO-REOHCLBHSA-N 3-sulfino-L-alanine Chemical compound OC(=O)[C@@H](N)C[S@@](O)=O ADVPTQAUNPRNPO-REOHCLBHSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 241000218628 Ginkgo Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- QEFRNWWLZKMPFJ-ZXPFJRLXSA-N L-methionine (R)-S-oxide Chemical compound C[S@@](=O)CC[C@H]([NH3+])C([O-])=O QEFRNWWLZKMPFJ-ZXPFJRLXSA-N 0.000 description 1
- UCUNFLYVYCGDHP-BYPYZUCNSA-N L-methionine sulfone Chemical compound CS(=O)(=O)CC[C@H](N)C(O)=O UCUNFLYVYCGDHP-BYPYZUCNSA-N 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- ADVPTQAUNPRNPO-UHFFFAOYSA-N alpha-amino-beta-sulfino-propionic acid Natural products OC(=O)C(N)CS(O)=O ADVPTQAUNPRNPO-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000019261 food antioxidant Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- UIHPNZDZCOEZEN-YFKPBYRVSA-N methyl (2s)-2-amino-4-methylsulfanylbutanoate Chemical compound COC(=O)[C@@H](N)CCSC UIHPNZDZCOEZEN-YFKPBYRVSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 235000021195 test diet Nutrition 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本出願は、2003年7月3日に出願され、2003年7月3日の同じ出願日を有する仮出願(出願番号不明)に2004年7月1日に変更され、本明細書においてその全体を引用する米国出願第10/613、604号の恩典を請求する。
約1〜15ppmのベータ−カロテンを用いることができる。
約0.1〜約5ppmまでのセレンを用いることができる。
少なくとも約5ppmのルテインを用いることができる。
少なくとも約25ppmのトコトリエノールを用いることができる。
少なくとも約25ppmの補酵素Q10を用いることができる。
少なくとも約25ppmの大豆イソフラボンを使用できる。
少なくとも50ppmの抽出物または食餌の1%のイチョウを使用できる。
Claims (4)
- 猫における精神能力の劣化を減少させる方法であって、メチオニン、システイン、およびそれらの混合物からなる群から選択される少なくとも1つの含硫抗酸化剤、少なくとも1つのオメガ−3脂肪酸、及びビタミンE、ビタミンC、l−カルニチンを含む追加の抗酸化剤、を含む食餌組成物を前記猫に供給することを含み、メチオニンは乾物ベースで食餌組成物の1.0重量%〜1.5重量%の量であり、システインは乾物ベースで食餌組成物の0.4重量%〜0.7重量%の量であり、システイン及びメチオニンの混合物は全量で乾物ベースで食餌組成物の1.4重量%〜2.2重量%であり、オメガ−3脂肪酸は少なくとも0.2重量%の量であり、ビタミンEは少なくとも300ppmの量であり、ビタミンCは少なくとも100ppmの量であり、及びl−カルニチンは少なくとも500ppmの量であり、
精神能力の、減少した劣化の指標として、活動性が増大し、
前記少なくとも1つのオメガ−3脂肪酸は、ドコサヘキサエン酸、エイコサペンタエン酸、アルファ−リノレン酸及びこれらの組合せからなる群から選択される、方法。 - メチオニン、システイン、およびそれらの混合物からなる群から選択される少なくとも1つの含硫抗酸化剤、少なくとも1つのオメガ−3脂肪酸、並びにビタミンE、ビタミンC、及びl−カルニチンを含む追加の抗酸化剤を含む、猫において精神能力の劣化を減少させるための猫用の食餌組成物において、メチオニンは乾物ベースで食餌組成物の1.0重量%〜1.5重量%の量であり、システインは乾物ベースで食餌組成物の0.4重量%〜0.7重量%の量であり、メチオニンとシステインの混合物は全量で、乾物ベースで食餌組成物の1.4重量%〜2.2重量%であり、オメガ−3脂肪酸は少なくとも0.2重量%の量であり、ビタミンEは少なくとも300ppmの量であり、ビタミンCは少なくとも100ppmの量であり、l−カルニチンは少なくとも500ppmの量であり、
精神能力の、減少した劣化の指標として、活動性が増大し、
前記少なくとも1つのオメガ−3脂肪酸は、ドコサヘキサエン酸、エイコサペンタエン酸、アルファ−リノレン酸及びこれらの組合せからなる群から選択される、組成物。 - メチオニンは乾物ベースで食餌組成物の1.1重量%〜1.5重量%の量であり、システインは乾物ベースで食餌組成物の0.5重量%〜0.7重量%の量であり、メチオニンとシステインの混合物は全量で、乾物ベースで食餌組成物の1.5重量%〜2.2重量%であり、オメガ−3脂肪酸は少なくとも0.3重量%の量であり、ビタミンEは少なくとも500ppmの量であり、ビタミンCは少なくとも200ppmの量である、請求項2記載の組成物。
- メチオニンとシステインの混合物は全量で、乾物ベースで食餌組成物の1.6重量%〜2.2重量%である、請求項3記載の組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61360403A | 2003-07-03 | 2003-07-03 | |
US10/613,604 | 2003-07-03 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006518910A Division JP2007524402A (ja) | 2003-07-03 | 2004-07-02 | コンパニオン動物における精神活動の加齢劣化を減少させる組成物及び方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012100673A JP2012100673A (ja) | 2012-05-31 |
JP6049258B2 true JP6049258B2 (ja) | 2016-12-21 |
Family
ID=34079620
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006518910A Pending JP2007524402A (ja) | 2003-07-03 | 2004-07-02 | コンパニオン動物における精神活動の加齢劣化を減少させる組成物及び方法 |
JP2011289115A Expired - Lifetime JP6049258B2 (ja) | 2003-07-03 | 2011-12-28 | コンパニオン動物における精神活動の加齢劣化を減少させる組成物及び方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006518910A Pending JP2007524402A (ja) | 2003-07-03 | 2004-07-02 | コンパニオン動物における精神活動の加齢劣化を減少させる組成物及び方法 |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1641351B1 (ja) |
JP (2) | JP2007524402A (ja) |
CN (2) | CN103988988B (ja) |
AU (1) | AU2004257684B2 (ja) |
BR (1) | BRPI0412132B1 (ja) |
DK (1) | DK1641351T3 (ja) |
ES (1) | ES2479944T3 (ja) |
MX (1) | MXPA05013755A (ja) |
RU (1) | RU2349312C2 (ja) |
WO (1) | WO2005006877A1 (ja) |
ZA (1) | ZA200510338B (ja) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020076470A1 (en) | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
BRPI0412332A (pt) | 2003-07-07 | 2006-09-05 | Hills Pet Nutrition Inc | método para aumentar nìveis de antioxidante no sangue em um felino, e, composição para dieta adequada para alimentar animais de companhia jovens |
US8921422B2 (en) | 2003-10-01 | 2014-12-30 | The Iams Company | Methods and kits for enhancing ability to learn in a puppy or kitten |
US8377904B2 (en) * | 2004-02-09 | 2013-02-19 | Hill's Pet Nutrition, Inc. | Composition and method for use in cartilage affecting conditions |
US8205012B2 (en) | 2004-03-24 | 2012-06-19 | Electronics For Imaging, Inc. | Directory server for automatic network information access systems |
RU2433819C2 (ru) | 2004-11-09 | 2011-11-20 | Хилл'С Пет Ньютришн, Инк. | Применение антиоксидантов для модуляции генов |
WO2006071919A2 (en) | 2004-12-29 | 2006-07-06 | Hill's Pet Nutrition, Inc. | Methods for inhibiting a decline in learning and/or memory in animals |
US8252742B2 (en) | 2004-12-30 | 2012-08-28 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
CN101150962A (zh) | 2004-12-30 | 2008-03-26 | 希尔氏宠物营养品公司 | 提高幼年动物生活质量的方法 |
FR2884421B1 (fr) | 2005-04-15 | 2007-08-10 | Virbac Sa | Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie |
CN101262780B (zh) | 2005-07-14 | 2013-04-24 | 希尔氏宠物营养品公司 | 一种延长动物生命的方法 |
JP4903796B2 (ja) | 2005-08-17 | 2012-03-28 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 腎疾患の予防及び治療のための方法及び組成物 |
EP2305222A1 (en) * | 2006-04-04 | 2011-04-06 | Hill's Pet Nutrition, Inc. | Compositions and methods for enhancing the antioxidant status of animals |
CA2654303C (en) | 2006-06-08 | 2016-07-26 | The Iams Company | Use of at least one polyphenol for promoting eye health |
WO2008103958A1 (en) * | 2007-02-22 | 2008-08-28 | Hill's Pet Nutrition, Inc. | Compositions and methods for altering gene expression |
CN101951786A (zh) | 2007-12-21 | 2011-01-19 | 希尔氏宠物营养品公司 | 宠物食品组合物 |
CN105267969A (zh) | 2008-01-04 | 2016-01-27 | 雀巢产品技术援助有限公司 | 包含不饱和脂肪酸和一氧化氮释放化合物的组合物及其用于增强认知和相关功能的用途 |
BRPI0915974A2 (pt) * | 2008-07-18 | 2017-05-30 | Hill´S Pet Nutrition Inc | métodos para modular funções biológicas, para tratar um animal sofrendo de um distúrbio ou doença, para alterar a expressão de pelo menos um peptídeo em um mamífero, e para triar um ou mais compostos de teste para habilidade para alterar a expressão de pelo menos um gene de interesse em um mamífero |
JP2014018172A (ja) * | 2012-07-20 | 2014-02-03 | Kohjin Life Sciences Co Ltd | 過酸化脂質生成を抑制するペットフード |
GB201908111D0 (en) * | 2019-06-06 | 2019-07-24 | Mars Inc | Modulation of the oral microbiota |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5995851A (ja) * | 1982-11-22 | 1984-06-02 | Nippon Doubutsu Yakuhin Kk | 犬猫用食品補助物 |
JP2758964B2 (ja) * | 1990-03-20 | 1998-05-28 | 日清製粉株式会社 | 犬猫用飲料 |
JPH04166039A (ja) * | 1990-10-26 | 1992-06-11 | Hirotoshi Yokura | ペットフード |
JP3347381B2 (ja) * | 1993-01-27 | 2002-11-20 | 協和醗酵工業株式会社 | ペットフード |
JPH0750997A (ja) * | 1993-08-09 | 1995-02-28 | Yaizu Suisan Kagaku Kogyo Kk | 動物の成長促進物質及び飼料 |
CA2147109A1 (en) * | 1994-04-18 | 1995-10-19 | Gregory A. Reinhart | Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses |
NZ527924A (en) * | 1999-01-29 | 2005-01-28 | Mars Uk Ltd | Antioxidant compositions and methods for companion animals |
IL148142A (en) * | 1999-09-09 | 2005-06-19 | Nestle Sa | Method for improving condition of elderly pets and pet food therefor |
WO2001058271A1 (en) * | 2000-01-25 | 2001-08-16 | Juvenon, Inc. | Nutritional supplements for aged pets |
US20020044988A1 (en) * | 2000-08-22 | 2002-04-18 | Fuchs Eileen C. | Nutritional composition and method for improving protein deposition |
US20020115710A1 (en) * | 2000-10-31 | 2002-08-22 | Zicker Steven Curtis | Composition and method |
JP2002180082A (ja) * | 2000-12-11 | 2002-06-26 | Maruha Corp | 摂取物 |
AU784852B2 (en) * | 2001-08-10 | 2006-07-06 | Mars, Incorporated | Canine support diet |
CN1364418A (zh) * | 2001-11-30 | 2002-08-21 | 赵桂华 | 一种健脑益智的乳制品和再加工食品 |
-
2004
- 2004-07-02 JP JP2006518910A patent/JP2007524402A/ja active Pending
- 2004-07-02 ES ES04756797.9T patent/ES2479944T3/es not_active Expired - Lifetime
- 2004-07-02 WO PCT/US2004/021930 patent/WO2005006877A1/en active Application Filing
- 2004-07-02 AU AU2004257684A patent/AU2004257684B2/en not_active Ceased
- 2004-07-02 MX MXPA05013755A patent/MXPA05013755A/es active IP Right Grant
- 2004-07-02 CN CN201410115999.4A patent/CN103988988B/zh not_active Expired - Fee Related
- 2004-07-02 RU RU2006103070/13A patent/RU2349312C2/ru not_active IP Right Cessation
- 2004-07-02 EP EP04756797.9A patent/EP1641351B1/en not_active Expired - Lifetime
- 2004-07-02 CN CNA2004800191323A patent/CN1816284A/zh active Pending
- 2004-07-02 BR BRPI0412132-5B1A patent/BRPI0412132B1/pt not_active IP Right Cessation
- 2004-07-02 DK DK04756797.9T patent/DK1641351T3/da active
-
2005
- 2005-12-20 ZA ZA200510338A patent/ZA200510338B/en unknown
-
2011
- 2011-12-28 JP JP2011289115A patent/JP6049258B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2007524402A (ja) | 2007-08-30 |
WO2005006877A1 (en) | 2005-01-27 |
DK1641351T3 (da) | 2014-08-25 |
CN1816284A (zh) | 2006-08-09 |
JP2012100673A (ja) | 2012-05-31 |
EP1641351A1 (en) | 2006-04-05 |
ZA200510338B (en) | 2007-04-25 |
CN103988988B (zh) | 2017-04-26 |
ES2479944T3 (es) | 2014-07-25 |
MXPA05013755A (es) | 2006-03-08 |
CN103988988A (zh) | 2014-08-20 |
RU2349312C2 (ru) | 2009-03-20 |
AU2004257684B2 (en) | 2010-08-26 |
BRPI0412132A (pt) | 2006-08-15 |
RU2006103070A (ru) | 2006-06-10 |
BRPI0412132B1 (pt) | 2014-12-30 |
AU2004257684A1 (en) | 2005-01-27 |
EP1641351B1 (en) | 2014-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6049258B2 (ja) | コンパニオン動物における精神活動の加齢劣化を減少させる組成物及び方法 | |
JP6389214B2 (ja) | コンパニオンアニマルにおいて改良された酸化的状態を得るための組成物 | |
US8168161B2 (en) | Method to promote oral health in companion animals | |
EP3100616B1 (en) | Methods for enhancing the quality of life of a growing animal | |
DK2387325T3 (en) | Methods for improving liver and immune function in an animal | |
US20060141011A1 (en) | Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health | |
US20060002985A1 (en) | Compositions and methods for decreasing age-related deterioration in mental activities in companion animals | |
CA2495417C (en) | Compositions and methods for decreasing age-related deterioration in mental activities in companion animals | |
CN114828646A (zh) | 治疗和降低与升高的4-乙基苯基硫酸盐相关的病状风险的组合物和方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131224 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140320 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140326 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140423 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20150128 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150528 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20150709 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20151002 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20160413 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20160419 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160803 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160923 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20161122 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6049258 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |